Omacron

In the short term, omicron has every chance of usurping delta and becoming the dominant version of renovares. Companies have offered reassurances that the vaccine can be adjusted to deal with omacron and any variants that follow. Francois is optimistic that rounds of jabs and mild infections will mean that our immune systems will win out in the end.